A discussion of measures of enrichment in virtual screening: comparing the information content of descriptors with increasing levels of sophistication

scientific article published in September 2005

A discussion of measures of enrichment in virtual screening: comparing the information content of descriptors with increasing levels of sophistication is …
instance of (P31):
scholarly articleQ13442814

External links are
P8978DBLP publication IDjournals/jcisd/BenderG05
P356DOI10.1021/CI0500177
P698PubMed publication ID16180913
P5875ResearchGate publication ID7583053

P50authorRobert C GlenQ28946543
Andreas BenderQ28925563
P2093author name stringAndreas Bender
P2860cites workApproaches to Measure Chemical Similarity– a ReviewQ28531485
P433issue5
P921main subjectinformation contentQ735075
virtual screeningQ4112105
P304page(s)1369-1375
P577publication date2005-09-01
P1433published inJournal of Chemical Information and ModelingQ3007982
P1476titleA discussion of measures of enrichment in virtual screening: comparing the information content of descriptors with increasing levels of sophistication
P478volume45

Reverse relations

cites work (P2860)
Q27134895A Survey of Quantitative Descriptions of Molecular Structure
Q39300262Anti-HIV-1 Activity Prediction of Novel Gp41 Inhibitors Using Structure-Based Virtual Screening and Molecular Dynamics Simulation.
Q27998664Application of 3D Zernike descriptors to shape-based ligand similarity searching
Q34019272Application of NMR and molecular docking in structure-based drug discovery
Q51304233AutoDock-GIST: Incorporating Thermodynamics of Active-Site Water into Scoring Function for Accurate Protein-Ligand Docking.
Q92134160Bayesian semi-supervised learning for uncertainty-calibrated prediction of molecular properties and active learning
Q50622600Binding mode similarity measures for ranking of docking poses: a case study on the adenosine A2A receptor.
Q60046647Bioinformatics: A rational combine approach used for the identification and in-vitro activity evaluation of potent β-Glucuronidase inhibitors
Q82908096Can we really do computer-aided drug design?
Q56916101Chapter 9 Molecular Similarity: Advances in Methods, Applications and Validations in Virtual Screening and QSAR
Q30386769Comparing pharmacophore models derived from crystal structures and from molecular dynamics simulations
Q60238441Compound Ranking Based on Fuzzy Three-Dimensional Similarity Improves the Performance of Docking into Homology Models of G-Protein-Coupled Receptors
Q37790487Computational analysis of structure-activity relationships
Q34619242Computer-aided retrometabolic drug design: soft drugs
Q92636228Conformational Studies of Glucose Transporter 1 (GLUT1) as an Anticancer Drug Target
Q31163923Data mining using template-based molecular docking on tetrahydroimidazo-[4,5,1-jk][1,4]-benzodiazepinone (TIBO) derivatives as HIV-1RT inhibitors
Q38409890Dereplication: racing to speed up the natural products discovery process.
Q36803981Effects of histidine protonation and rotameric states on virtual screening of M. tuberculosis RmlC.
Q51070891Ensemble pharmacophore meets ensemble docking: a novel screening strategy for the identification of RIPK1 inhibitors.
Q50910256Ensembling and filtering: an effective and rapid in silico multitarget drug-design strategy to identify RIPK1 and RIPK3 inhibitors.
Q36548489Exploration of multiple Sortase A protein conformations in virtual screening
Q42874590Exploring different virtual screening strategies for acetylcholinesterase inhibitors
Q45965607Feature-map vectors: a new class of informative descriptors for computational drug discovery.
Q47114939High-throughput detection of antioxidants in mulberry fruit using correlations between high-resolution mass and activity profiles of chromatographic fractions
Q57937286High-throughput structural characterisation of therapeutic protein targets
Q34347842How similar are those molecules after all? Use two descriptors and you will have three different answers
Q53092961Identification of InhA inhibitors: A combination of virtual screening, molecular dynamics simulations and quantum chemical studies.
Q51632843Identification of new dual spleen tyrosine kinase (Syk) and phosphoionositide-3-kinase δ (PI3Kδ) inhibitors using ligand and structure-based integrated ideal pharmacophore models.
Q89174818Improving Prediction Accuracy of Binding Free Energies and Poses of HIV Integrase Complexes Using the Binding Energy Distribution Analysis Method with Flattening Potentials
Q33309163Integrating high-content screening and ligand-target prediction to identify mechanism of action
Q54172917Ligand-based and e-pharmacophore modeling, 3D-QSAR and hierarchical virtual screening to identify dual inhibitors of spleen tyrosine kinase (Syk) and janus kinase 3 (JAK3).
Q45383758Modelling ligand selectivity of serine proteases using integrative proteochemometric approaches improves model performance and allows the multi-target dependent interpretation of features
Q50955211Modelling the molecular mechanism of protein-protein interactions and their inhibition: CypD-p53 case study.
Q90226731Molecular Modeling Studies on the Binding Mode of the PD-1/PD-L1 Complex Inhibitors
Q47401024Molecular dynamics and integrated pharmacophore-based identification of dual [Formula: see text] inhibitors.
Q47788380Optimization of compound ranking for structure-based virtual ligand screening using an established FRED-Surflex consensus approach
Q39647348Pose prediction and virtual screening performance of GOLD scoring functions in a standardized test.
Q42414848Predicting phospholipidosis using machine learning
Q33772055Profiling diverse compounds by flux- and electrophysiology-based primary screens for inhibition of human Ether-à-go-go related gene potassium channels
Q54152447Proteochemometric modeling as a tool to design selective compounds and for extrapolating to novel targets
Q89414823QEX: target-specific druglikeness filter enhances ligand-based virtual screening
Q34204731Recognizing pitfalls in virtual screening: a critical review
Q35185795Selective Mycobacterium tuberculosis Shikimate Kinase Inhibitors as Potential Antibacterials
Q36032595Structure- and sequence-based function prediction for non-homologous proteins
Q51918959Support vector inductive logic programming outperforms the naive Bayes classifier and inductive logic programming for the classification of bioactive chemical compounds.
Q28648497Template CoMFA Generates Single 3D-QSAR Models that, for Twelve of Twelve Biological Targets, Predict All ChEMBL-Tabulated Affinities
Q51530156Towards structure-based protein drug design.
Q28478426Understanding and classifying metabolite space and metabolite-likeness
Q38750923Why network approach can promote a new way of thinking in biology.
Q46052028kNNsim: k-nearest neighbors similarity with genetic algorithm features optimization enhances the prediction of activity classes for small molecules
Q47418570xMaP-An Interpretable Alignment-Free Four-Dimensional Quantitative Structure-Activity Relationship Technique Based on Molecular Surface Properties and Conformer Ensembles

Search more.